|
US7351834B1
(en)
|
1999-01-13 |
2008-04-01 |
Bayer Pharmaceuticals Corporation |
ω-Carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
|
|
US8124630B2
(en)
|
1999-01-13 |
2012-02-28 |
Bayer Healthcare Llc |
ω-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
|
|
ATE538794T1
(de)
|
1999-01-13 |
2012-01-15 |
Bayer Healthcare Llc |
Gamma carboxyarylsubstituierte diphenylharnstoffverbindungen als p38 kinasehemmer
|
|
MXPA04007832A
(es)
|
2002-02-11 |
2005-09-08 |
Bayer Pharmaceuticals Corp |
Aril-ureas con actividad inhibitoria de angiogenesis.
|
|
WO2003068229A1
(en)
|
2002-02-11 |
2003-08-21 |
Bayer Pharmaceuticals Corporation |
Pyridine, quinoline, and isoquinoline n-oxides as kinase inhibitors
|
|
NZ535985A
(en)
*
|
2002-03-29 |
2007-04-27 |
Chiron Corp |
Substituted benzazoles and use thereof as RAF kinase inhibitors
|
|
US7557129B2
(en)
|
2003-02-28 |
2009-07-07 |
Bayer Healthcare Llc |
Cyanopyridine derivatives useful in the treatment of cancer and other disorders
|
|
MXPA05012377A
(es)
|
2003-05-15 |
2006-05-25 |
Arqule Inc |
Derivados de imidazotiazoles e imidazoxazol como inhibidores de p38.
|
|
WO2004113274A2
(en)
|
2003-05-20 |
2004-12-29 |
Bayer Pharmaceuticals Corporation |
Diaryl ureas with kinase inhibiting activity
|
|
EA010485B1
(ru)
|
2003-07-23 |
2008-10-30 |
Байер Фамэсьютиклс Копэрейшн |
Производное n,n'-дифенилмочевины, фармацевтическая композиция (варианты) и способ лечения и предупреждения заболеваний и состояний с его использованием (варианты)
|
|
PT1682126E
(pt)
*
|
2003-10-16 |
2009-10-02 |
Novartis Vaccines & Diagnostic |
Benzazois substituídos e sua utilização como inibidores da quinase raf
|
|
WO2006010082A1
(en)
*
|
2004-07-08 |
2006-01-26 |
Arqule, Inc. |
1,4-disubstituted naphtalenes as inhibitors of p38 map kinase
|
|
JP2008517064A
(ja)
*
|
2004-10-19 |
2008-05-22 |
アークル インコーポレイテッド |
Ｐ３８ｍａｐキナーゼのイミダゾオキサゾールおよびイミダゾチアゾール阻害剤の合成
|
|
US7429608B2
(en)
*
|
2005-01-20 |
2008-09-30 |
Amgen Inc. |
Benzo[d]imidazol analogs as vanilloid receptor ligands and their use in treatments
|
|
TWI370820B
(en)
*
|
2005-04-27 |
2012-08-21 |
Takeda Pharmaceutical |
Fused heterocyclic compounds
|
|
PE20070335A1
(es)
|
2005-08-30 |
2007-04-21 |
Novartis Ag |
Benzimidazoles sustituidos y metodos para su preparacion
|
|
US7939528B2
(en)
*
|
2005-10-13 |
2011-05-10 |
Glaxosmithkline Llc |
Heterocycle compounds
|
|
CN102633783A
(zh)
|
2006-02-10 |
2012-08-15 |
转化技术制药公司 |
作为Aurora激酶抑制剂的苯并唑系衍生物、组合物和使用方法
|
|
PE20080359A1
(es)
|
2006-04-19 |
2008-06-06 |
Novartis Ag |
Compuestos de benzoxazol y benzotiazol 6-0-sustituidos y metodos de inhibicion de la senalizacion de csf-1r
|
|
EP2046292B1
(en)
|
2006-07-21 |
2010-03-03 |
Novartis AG |
Formulations for benzimidazolyl pyridyl ethers
|
|
PE20080766A1
(es)
*
|
2006-08-30 |
2008-06-15 |
Novartis Ag |
Sales de benzimidazolil piridil eteres y formulaciones que las contienen
|
|
AU2008239179B2
(en)
*
|
2007-04-05 |
2011-02-24 |
Daiichi Sankyo Company, Limited |
Fused bicyclic heteroaryl derivatives
|
|
CL2008001626A1
(es)
|
2007-06-05 |
2009-06-05 |
Takeda Pharmaceuticals Co |
Compuestos derivados de heterociclos fusionados, agente farmaceutico que los comprende y su uso en la profilaxis y tratamiento del cancer.
|
|
EP2181987B9
(en)
|
2007-08-23 |
2014-09-03 |
Takeda Pharmaceutical Company Limited |
2-Carbonylaminobenzothiazoles and their use for the prophylaxis and treatment of cancer
|
|
US8344135B2
(en)
|
2007-08-29 |
2013-01-01 |
Takeda Pharmaceutical Company Limited |
Heterocyclic compound and use thereof
|
|
AU2008305294B2
(en)
|
2007-09-21 |
2012-11-29 |
Array Biopharma Inc. |
Pyridin-2 -yl-amino-1, 2, 4 -thiadiazole derivatives as glucokinase activators for the treatment of diabetes mellitus
|
|
MX2010004246A
(es)
*
|
2007-10-18 |
2010-04-30 |
Novartis Ag |
Inhibidores de csf-1r para el tratamiento de cancer y de enfermedades oseas.
|
|
US8697874B2
(en)
*
|
2008-12-01 |
2014-04-15 |
Takeda Pharmaceutical Company Limited |
Heterocyclic compound and use thereof
|
|
JO3101B1
(ar)
|
2008-12-02 |
2017-09-20 |
Takeda Pharmaceuticals Co |
مشتقات بنزوثيازول كعوامل مضادة للسرطان
|
|
CN102317293A
(zh)
*
|
2008-12-05 |
2012-01-11 |
艾科尔公司 |
Raf抑制剂及其用途
|
|
KR20110123253A
(ko)
|
2009-03-05 |
2011-11-14 |
다이이찌 산쿄 가부시키가이샤 |
피리딘 유도체
|
|
JP2013529968A
(ja)
|
2010-06-11 |
2013-07-25 |
スミス アンド ネフュー インコーポレーテッド |
患者に適合した器具
|
|
JP2013531687A
(ja)
|
2010-07-16 |
2013-08-08 |
パーデュー、ファーマ、リミテッド、パートナーシップ |
ナトリウムチャネル遮断剤としてのピリジン化合物
|
|
EP2616441B1
(en)
|
2010-09-17 |
2019-08-07 |
Purdue Pharma L.P. |
Pyridine compounds and the uses thereof
|
|
CN102276482A
(zh)
*
|
2011-04-11 |
2011-12-14 |
常州大学 |
2-甲氧基-5-溴苯胺的制备方法
|
|
US9408885B2
(en)
|
2011-12-01 |
2016-08-09 |
Vib Vzw |
Combinations of therapeutic agents for treating melanoma
|
|
WO2013136170A1
(en)
|
2012-03-16 |
2013-09-19 |
Purdue Pharma L.P. |
Substituted pyridines as sodium channel blockers
|
|
WO2014096941A1
(en)
|
2012-12-20 |
2014-06-26 |
Purdue Pharma L.P. |
Cyclic sulfonamides as sodium channel blockers
|
|
US9242969B2
(en)
|
2013-03-14 |
2016-01-26 |
Novartis Ag |
Biaryl amide compounds as kinase inhibitors
|
|
CN103435554A
(zh)
*
|
2013-09-06 |
2013-12-11 |
中国药科大学 |
2-苯氨基苯并咪唑类化合物及其用途
|
|
WO2015041534A1
(en)
|
2013-09-20 |
2015-03-26 |
Stichting Het Nederlands Kanker Instituut |
P90rsk in combination with raf/erk/mek
|
|
EP3046557A1
(en)
|
2013-09-20 |
2016-07-27 |
Stichting Het Nederlands Kanker Instituut |
Rock in combination with mapk-pathway
|
|
US10730866B2
(en)
|
2014-04-07 |
2020-08-04 |
Purdue Pharma L.P. |
Indole derivatives and use thereof
|
|
US20170027940A1
(en)
|
2014-04-10 |
2017-02-02 |
Stichting Het Nederlands Kanker Instituut |
Method for treating cancer
|
|
WO2015178770A1
(en)
|
2014-05-19 |
2015-11-26 |
Stichting Het Nederlands Kanker Instituut |
Compositions for cancer treatment
|
|
UY36294A
(es)
|
2014-09-12 |
2016-04-29 |
Novartis Ag |
Compuestos y composiciones como inhibidores de quinasa
|
|
WO2016100184A1
(en)
|
2014-12-16 |
2016-06-23 |
Forum Pharmaceuticals, Inc. |
Geminal substituted quinuclidine amide compounds as agonists of alpha-7 nicotinic acetylcholine receptors
|
|
CN105949178B
(zh)
*
|
2015-03-09 |
2020-05-26 |
西格莱(苏州)生物医药有限公司 |
一种苯并咪唑类化合物、其制备方法、中间体及应用
|
|
MX2017016231A
(es)
|
2015-06-10 |
2018-11-29 |
Axovant Sciences Gmbh |
Compuestos de aminobencisoxazol como agonistas de receptores a7-nicotínicos de acetilcolina.
|
|
WO2017027600A1
(en)
|
2015-08-12 |
2017-02-16 |
Forum Pharmaceuticals, Inc. |
GEMINAL SUBSTITUTED AMINOBENZISOXAZOLE COMPOUNDS AS AGONISTS OF α7-NICOTINIC ACETYLCHOLINE RECEPTORS
|
|
KR101770310B1
(ko)
|
2015-08-24 |
2017-08-24 |
이화여자대학교 산학협력단 |
2-(페닐아미노)벤조[d]옥사졸-5-올 유도체, 이의 제조방법 및 이를 유효성분으로 함유하는 염증성 질환의 예방 또는 치료용 약학적 조성물
|
|
US11028055B2
(en)
*
|
2015-11-30 |
2021-06-08 |
Children's Medical Center Corporation |
Compounds for treating proliferative diseases
|
|
AU2017329090B9
(en)
|
2016-09-19 |
2019-09-05 |
Novartis Ag |
Therapeutic combinations comprising a RAF inhibitor and a ERK inhibitor
|
|
CN106674264A
(zh)
*
|
2016-12-20 |
2017-05-17 |
苏州汉德创宏生化科技有限公司 |
(2,2,2‑三氟乙氧基)苯硼酸类化合物的合成方法
|
|
JP7341060B2
(ja)
|
2017-02-10 |
2023-09-08 |
アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル |
Ｍａｐｋ経路の活性化に関連付けられる癌の処置のための方法及び医薬組成物
|
|
US11242332B2
(en)
|
2017-03-15 |
2022-02-08 |
Sumitomo Dainippon Pharma Co., Ltd. |
Method for producing benzimidazole derivative
|
|
ES2952265T3
(es)
|
2017-05-02 |
2023-10-30 |
Novartis Ag |
Terapia combinada que comprende un inhibidor de Raf y trametinib
|
|
JP7234201B2
(ja)
*
|
2017-07-12 |
2023-03-07 |
ブリストル－マイヤーズ スクイブ カンパニー |
心不全の治療のためのｒｏｃｋの５員アミノヘテロ環および５，６－または６，６員二環式アミノヘテロ環の阻害剤
|
|
US11339157B1
(en)
|
2017-10-24 |
2022-05-24 |
Bayer Aktiengesellschaft |
4H-pyrrolo[3,2-c]pyridin-4-one derivatives
|
|
EP3732285A1
(en)
|
2017-12-28 |
2020-11-04 |
Tract Pharmaceuticals, Inc. |
Stem cell culture systems for columnar epithelial stem cells, and uses related thereto
|
|
WO2019156438A1
(en)
*
|
2018-02-07 |
2019-08-15 |
Korea Research Institute Of Chemical Technology |
Hetero ring-fused phenyl compounds for inhibiting tnik and medical uses thereof
|
|
JP2022500385A
(ja)
|
2018-09-10 |
2022-01-04 |
ミラティ セラピューティクス， インコーポレイテッド |
組み合わせ療法
|
|
WO2020097396A1
(en)
|
2018-11-07 |
2020-05-14 |
Dana-Farber Cancer Institute, Inc. |
Benzimidazole derivatives and aza-benzimidazole derivatives as janus kinase 2 inhibitors and uses thereof
|
|
EP3877371A4
(en)
|
2018-11-07 |
2022-07-27 |
Dana-Farber Cancer Institute, Inc. |
IMIDAZOPYRIDINE DERIVATIVES AND AZA-IMIDAZOPYRIDINE DERIVATIVES AS JANUS KINASE 2 INHIBITORS AND USES THEREOF
|
|
WO2020097398A1
(en)
|
2018-11-07 |
2020-05-14 |
Dana-Farber Cancer Institute, Inc. |
Benzothiazole derivatives and 7-aza-benzothiazole derivatives as janus kinase 2 inhibitors and uses thereof
|
|
WO2020216773A1
(en)
|
2019-04-24 |
2020-10-29 |
Bayer Aktiengesellschaft |
4h-pyrrolo[3,2-c]pyridin-4-one compounds
|
|
GEAP202415804A
(en)
|
2019-04-24 |
2024-02-12 |
Bayer Ag |
4h-pyrrolo[3,2-c]pyridin-4-one compounds
|
|
EP3958865B1
(en)
|
2019-04-24 |
2025-12-10 |
Bayer Aktiengesellschaft |
4h-pyrrolo[3,2-c]pyridin-4-one derivatives
|
|
ES3025633T3
(en)
|
2019-05-13 |
2025-06-09 |
Novartis Ag |
New crystalline forms of n-(3-(2-(2-hydroxyethoxy)-6-morpholinopyridin-4-yl)-4-methvlphenyl)-2(trifluoromethyl)isonicotinamide as raf inhibitors for the treatment of cancer
|
|
WO2021198020A1
(en)
|
2020-03-31 |
2021-10-07 |
Bayer Aktiengesellschaft |
3-(anilino)-2-[3-(3-alkoxy-pyridin-4-yl]-1,5,6,7-tetrahydro-4h-pyrrolo[3,2-c]pyridin-4-one derivatives as egfr inhibitors for the treatment of cancer
|
|
CA3181537A1
(en)
*
|
2020-05-06 |
2021-11-11 |
Ajax Therapeutics, Inc. |
6-heteroaryloxy benzimidazoles and azabenzimidazoles as jak2 inhibitors
|
|
WO2022133098A2
(en)
*
|
2020-12-16 |
2022-06-23 |
Ifm Due, Inc. |
Compounds and compositions for treating conditions associated with sting activity
|
|
EP4267574B1
(en)
|
2020-12-23 |
2025-04-23 |
Ajax Therapeutics, Inc. |
6-heteroaryloxy benzimidazoles and azabenzimidazoles as jak2 inhibitors
|
|
WO2023009708A1
(en)
*
|
2021-07-29 |
2023-02-02 |
Ajax Therapeutics, Inc. |
Heteroaryloxy triazolo- and imidazo-azines as jak2 inhibitors
|
|
TW202325289A
(zh)
|
2021-11-09 |
2023-07-01 |
美商雅捷可斯治療公司 |
Ｊａｋ２抑制劑之形式及組合物
|
|
JP7782035B2
(ja)
|
2021-11-09 |
2025-12-08 |
エイジャックス セラピューティクス， インコーポレイテッド |
Ｊａｋ２阻害剤としての６－ヘテロアリールオキシベンゾイミダゾール及びアザベンゾイミダゾール
|